Efficacy of bi-weekly docetaxel in hormone-sensitive metastatic prostate cancer (mHSPC).

被引：0
|
作者：
Lombana Quinonez, Milton Alberto
Milena Torres, Ana
Gonzalez, Guido
机构：
[1] Ctr Integral Canc Clin Occidente, Cali, Colombia
[2] Nalt Med Solut, Cali, Colombia
[3] Clin Occidente, Cali, Colombia
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2023年 / 41卷 / 16期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
e17070
引用
收藏
页数：1
相关论文
共 50 条
  • [41] Management of Metastatic Hormone-Sensitive Prostate Cancer
    Bernard, Brandon
    Sweeney, Christopher J.
    CURRENT UROLOGY REPORTS, 2015, 16 (03)
  • [42] Comparative assessment of docetaxel for safety and efficacy between hormone-sensitive and castration-resistant metastatic prostate cancer
    Mager, Rene
    Savko, Olga
    Boehm, Katharina
    Thomas, Anita
    Dotzauer, Robert
    Borgmann, Hendrik
    Jaeger, Wolfgang
    Thomas, Christian
    Haferkamp, Axel
    Hoefner, Thomas
    Tsaur, Igor
    UROLOGIC ONCOLOGY-SEMINARS AND ORIGINAL INVESTIGATIONS, 2019, 37 (12) : 999 - 1005
  • [43] Management of Metastatic Hormone-Sensitive Prostate Cancer
    Brandon Bernard
    Christopher J. Sweeney
    Current Urology Reports, 2015, 16
  • [44] Update on Metastatic Hormone-Sensitive Prostate Cancer
    Chi, Kim N.
    CLINICAL ADVANCES IN HEMATOLOGY & ONCOLOGY, 2022, 20 (05) : 277 - 280
  • [45] Management of Hormone-Sensitive Metastatic Prostate Cancer
    Agarwal, Neeraj
    Hussain, Maha
    HEMATOLOGY-ONCOLOGY CLINICS OF NORTH AMERICA, 2013, 27 (06) : 1221 - +
  • [46] QUALITATIVE EXPLORATION OF THE REAL-WORLD EXPERIENCES OF MEN RECEIVING OR REFUSING CHEMOTHERAPY (DOCETAXEL) FOR THE TREATMENT OF METASTATIC HORMONE-SENSITIVE PROSTATE CANCER (MHSPC)
    Ito, T.
    Grant, L.
    Mills, A.
    Heselwood, A.
    Gater, A.
    VALUE IN HEALTH, 2017, 20 (09) : A450 - A450
  • [47] Indirect comparison of abiraterone acetate and docetaxel for treatment of metastatic "hormone-sensitive" prostate cancer
    Feyerabend, S.
    Saad, F.
    Li, T.
    Ito, T.
    Diels, J.
    Van Sanden, S.
    De Porre, P.
    Roiz, J.
    Abogunrin, S.
    Fizazi, K.
    ANNALS OF ONCOLOGY, 2017, 28
  • [48] Abiraterone vs. docetaxel for metastatic hormone-sensitive prostate cancer: A microsimulation model
    Hird, Amanda E.
    Magee, Diana E.
    Cheung, Douglas C.
    Matta, Rano
    Kulkarni, Girish S.
    Nam, Robert K.
    CUAJ-CANADIAN UROLOGICAL ASSOCIATION JOURNAL, 2020, 14 (09): : E418 - E427
  • [49] Pros and cons of docetaxel used to treat metastatic hormone-sensitive prostate cancer: The cons
    Suzuki, Kazuhiro
    ANNALS OF ONCOLOGY, 2016, 27
  • [50] Docetaxel-related toxicity in metastatic hormone-sensitive and metastatic castration-resistant prostate cancer
    Schweizer, Michael T.
    Gulati, Roman
    Mostaghel, Elahe A.
    Nelson, Peter S.
    Montgomery, R. Bruce
    Yu, Evan Y.
    Cheng, Heather H.
    MEDICAL ONCOLOGY, 2016, 33 (07)
12345